Jaime Rodriguez‐Canales

Author

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

Hongzhen Li, Iván L. Mojica, J A Rodriguez, J Chaves Rodriguez, J Rodriguez, J Rodriguez-Canales, J Rodriguez‐Canales, J. Rodriguez, J. Rodriguez-Canales, J., Rodriguez-Canales

451

Publications

17K

Citations

H-Index

153

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center National Cancer Institute National Institutes of Health Center for Cancer Research The University of Texas Southwestern Medical Center

About

Jaime Rodriguez‐Canales is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pathology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	36	59	6K
2	Health Sciences	9	9	616
3	Engineering	8	8	361
4	Natural Sciences	1	1	300
5	Public Health	1	1	46

Jaime Rodriguez‐Canales

146

Publications

16K

Citations

H-Index

Page 1

	Year	Citations
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Cancer Discovery	2018	1.5K
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial Hussein A. Tawbi, Melissa Burgess, Vanessa Bolejack, The Lancet Oncology OncologyPathologyAdvanced Soft-tissue SarcomaBone SarcomaImmune Checkpoint Inhibitor	2017	1.4K
Phase I Study of DNX-2401 (Delta-24-RGD) Oncolytic Adenovirus: Replication and Immunotherapeutic Effects in Recurrent Malignant Glioma Frederick F. Lang, Charles A. Conrad, Candelaria Gomez‐Manzano, Journal of Clinical Oncology	2018	672
Gene Expression Profiles in Paraffin-Embedded Core Biopsy Tissue Predict Response to Chemotherapy in Women With Locally Advanced Breast Cancer Luca Gianni, Milvia Zambetti, Kim Clark, Journal of Clinical Oncology	2005	616
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5 Xiang‐Ping Yang, Kamran Ghoreschi, Scott Steward-Tharp, Nature Immunology InflammationCytokineImmune Cell DevelopmentImmunologyImmune Regulation	2011	572
A Patient-Derived, Pan-Cancer EMT Signature Identifies Global Molecular Alterations and Immune Target Enrichment Following Epithelial-to-Mesenchymal Transition Milena Perez Mak, Pan Tong, Lixia Diao, Clinical Cancer Research	2015	560
CD38-Mediated Immunosuppression as a Mechanism of Tumor Cell Escape from PD-1/PD-L1 Blockade Limo Chen, Lixia Diao, Yongbin Yang, Cancer Discovery	2018	457
CPS1 maintains pyrimidine pools and DNA synthesis in KRAS/LKB1-mutant lung cancer cells Jiyeon Kim, Zeping Hu, Ling Cai, Nature ChromatinPyrimidine PoolsCell RegulationMedicineNatural Sciences	2017	300
Fatty Acid Oxidation Mediated by Acyl-CoA Synthetase Long Chain 3 Is Required for Mutant KRAS Lung Tumorigenesis Mahesh S. Padanad, Georgia Konstantinidou, Niranjan Venkateswaran, Cell Reports	2016	296
The Society for Immunotherapy of Cancer statement on best practices for multiplex immunohistochemistry (IHC) and immunofluorescence (IF) staining and validation Janis M. Taube, Güray Aktürk, Michael Angelo, Journal for ImmunoTherapy of Cancer	2020	275

Page 1